-
Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study
Cellier, C., Bouma, G., van Gils, T., Khater, S., Malamut, G., Crespo, L., Collin, P., Green, P. H. R., Crowe, S. E., Tsuji, W., Butz, E., Cerf-Bensussan, N., Macintyre, E., Parnes, J. R., Leon, F., Hermine, O., Mulder, C. J., Jabri, B., Murray, J., DiMarino, A., & 22 others, 1 Dec 2019, In: The Lancet Gastroenterology and Hepatology. 4, 12, p. 960-970 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: A CELAC study
Cheminant, M., Bruneau, J., Malamut, G., Sibon, D., Guegan, N., van Gils, T., Cording, S., Trinquand, A., Verkarre, V., Lhermitte, L., Brousse, N., Jannot, A-S., Khater, S., Frenzel, L., Delarue, R., Suarez, F., Marçais, A., Mulder, C. J. J., Macintyre, E., Asnafi, V., & 8 others, 1 Aug 2019, In: Gut. 68, 8, p. 1396-1405Research output: Contribution to journal › Article › Academic › peer-review
-
Gamma-delta T lymphocytes in the diagnostic approach of coeliac disease
Nijeboer, P., van Gils, T., Reijm, M., Ooijevaar, R., Lissenberg-Witte, B. I., Bontkes, H. J., Mulder, C. J. J. & Bouma, G., 1 May 2019, In: Journal of Clinical Gastroenterology. 53, 5, p. E208-E213Research output: Contribution to journal › Article › Academic › peer-review
- All publications
